Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Carcinoma
Open-data reference.
39 US clinical trials · 21 currently recruiting
Active & Recent Trials
The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
NCT06995898
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
M.D. Anderson Cancer Center
NCT00991094
Lung Cancer Screening in High-risk Black Individuals
Massachusetts General Hospital
NCT05898594
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
Ronald Myers
NCT05679349
Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
M.D. Anderson Cancer Center
NCT04595422
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
Jonsson Comprehensive Cancer Center
NCT05978128
The Rise in Robotic Atypical Segmentectomies
M.D. Anderson Cancer Center
NCT04644952
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
City of Hope Medical Center
NCT06196008
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
OHSU Knight Cancer Institute
NCT05407168
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
M.D. Anderson Cancer Center
NCT04783168
Engagement of Veterans With Lung Cancer
Palo Alto Veterans Institute for Research
NCT07219251
CONNECTing to LungCare
University of California, San Francis
NCT06213532
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
City of Hope Medical Center
NCT05384769
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
M.D. Anderson Cancer Center
NCT06743308
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
University of Michigan Rogel Cancer Center
NCT07291414
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
Northwestern University
NCT05802186
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
M.D. Anderson Cancer Center
NCT04789681
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
Mayo Clinic
NCT06482073
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Stanford University
NCT03582124
Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
M.D. Anderson Cancer Center
NCT03422302
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Thomas Jefferson University
NCT05775939
Screening for Lung Cancer in Older Patients (PLCO Screening Trial)
National Cancer Institute (NCI)
NCT01696968
Yoga Program for Improving the Quality of Life in Couples Coping With Cancer
M.D. Anderson Cancer Center
NCT04607590
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
City of Hope Medical Center
NCT04905082
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
Fred Hutchinson Cancer Center
NCT04081779
Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer
M.D. Anderson Cancer Center
NCT05144542
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
NCT01366144
Evaluating the Impact of a Virtually Supervised Exercise Intervention and Group Counseling on Inflammation and the Microbiome of Smokers at High Risk for Lung Cancer, BE FIT Trial
Ohio State University Comprehensive Cancer Center
NCT06445192
Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer
Northwestern University
NCT04931017
Endobronchial Ultrasound-Guided Transbronchial Needle-Aspiration With Suction in Obtaining Samples From Patients With Suspected Nodal Metastatic Lung Cancer
Ohio State University Comprehensive Cancer Center
NCT04116970
MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer
National Cancer Institute (NCI)
NCT03300817
Evaluation of Canakinumab in High-Risk Former-Smokers
Peter Shields
NCT06038526
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Jonsson Comprehensive Cancer Center
NCT04147494
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
Julie L. Sutcliffe, Ph.D
NCT03164486
Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV
Fred Hutchinson Cancer Center
NCT04682301
Iloprost in Preventing Lung Cancer in Former Smokers
National Cancer Institute (NCI)
NCT02237183
Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air Study
Fred Hutchinson Cancer Center
NCT04922697
SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
University of Washington
NCT01982123
Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy
OHSU Knight Cancer Institute
NCT03135782
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 6 |
| Phase 2 | 3 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Lung Carcinoma Trial Landscape
ClinicalTrials.gov lists 39 US studies indexed under Lung Carcinoma, and 21 of those are currently open to recruitment — roughly 54% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Lung Carcinoma shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 9 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Lung Carcinoma is led by M.D. Anderson Cancer Center with 9 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 39 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Lung Carcinoma?
PlainTrial tracks 39 US clinical trials for Lung Carcinoma, of which 21 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Lung Carcinoma?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.